Zimmer Biomet Holdings, Inc.
NYSE:ZBH
108.41 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,394.2 | 6,939.9 | 6,827.3 | 7,024.5 | 7,982.2 | 7,932.9 | 7,824.1 | 7,683.9 | 5,997.8 | 4,673.3 | 4,623.4 | 4,471.7 | 4,451.8 | 4,220.2 | 4,095.4 | 4,121.1 | 3,897.5 | 3,495.4 | 3,286.1 | 2,980.9 | 1,901 | 1,372.4 | 1,178.6 | 1,040.6 | 939 | 861 |
| Cost of Revenue
| 2,731.2 | 2,019.5 | 1,960.4 | 2,128.3 | 2,252.6 | 2,271.9 | 2,132.9 | 2,374.9 | 1,856.6 | 1,249.8 | 1,286.1 | 1,125.2 | 1,122 | 1,012.4 | 990.8 | 997.3 | 875.9 | 780.1 | 739.4 | 779.9 | 516.2 | 344.8 | 325.9 | 290.9 | 269 | 265 |
| Gross Profit
| 4,663 | 4,920.4 | 4,866.9 | 4,896.2 | 5,729.6 | 5,661 | 5,691.2 | 5,309 | 4,141.2 | 3,423.5 | 3,337.3 | 3,346.5 | 3,329.8 | 3,207.8 | 3,104.6 | 3,123.8 | 3,021.6 | 2,715.3 | 2,546.7 | 2,201 | 1,384.8 | 1,027.6 | 852.7 | 749.7 | 670 | 596 |
| Gross Profit Ratio
| 0.631 | 0.709 | 0.713 | 0.697 | 0.718 | 0.714 | 0.727 | 0.691 | 0.69 | 0.733 | 0.722 | 0.748 | 0.748 | 0.76 | 0.758 | 0.758 | 0.775 | 0.777 | 0.775 | 0.738 | 0.728 | 0.749 | 0.723 | 0.72 | 0.714 | 0.692 |
| Reseach & Development Expenses
| 458.7 | 406 | 435.8 | 372 | 449.3 | 391.7 | 367.4 | 365.6 | 268.8 | 188.3 | 204.2 | 225.6 | 238.6 | 220 | 205.4 | 194 | 209.6 | 188.3 | 175.5 | 166.7 | 105.8 | 80.7 | 71.6 | 52 | 45 | 36 |
| General & Administrative Expenses
| 0 | 0 | 0 | 3,177.8 | 0 | 3,379.3 | 2,973.9 | 2,932.9 | 2,284.2 | 1,822.5 | 1,833.8 | 1,807.1 | 1,991.9 | 1,832.4 | 1,732.1 | 1,771.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 394 | 349 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -157.8 | 0 | 0 | -69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2,817.3 | 2,761.7 | 2,843.4 | 3,177.8 | 3,343.8 | 3,379.3 | 2,973.9 | 2,932.9 | 2,284.2 | 1,822.5 | 1,833.8 | 1,807.1 | 1,834.1 | 1,832.4 | 1,732.1 | 1,702.3 | 1,489.7 | 1,355.7 | 1,259.6 | 1,190 | 737.5 | 546 | 532.8 | 429.7 | 394 | 349 |
| Other Expenses
| -9.3 | 560.6 | 582.3 | 648.5 | 666.7 | -15.6 | -18.3 | -71.3 | -36.9 | -39.6 | 6 | 4.5 | 0 | 0 | 0 | 0 | 169.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 3,276 | 3,728.3 | 3,861.5 | 4,198.3 | 4,459.8 | 4,513.8 | 3,945.2 | 3,864.4 | 2,901.6 | 2,010.8 | 2,038 | 2,032.7 | 2,230.5 | 2,052.4 | 1,937.5 | 1,965.3 | 1,868.8 | 1,544 | 1,435.1 | 1,356.7 | 843.3 | 626.7 | 604.4 | 481.7 | 439 | 385 |
| Operating Income
| 1,387 | 1,064.1 | 860.3 | 723.3 | 1,137.5 | 33.8 | 823.2 | 827.9 | 326.4 | 1,034.7 | 1,035.6 | 1,047.4 | 1,024.1 | 916.7 | 1,018.8 | 1,090 | 1,127.6 | 1,165.2 | 1,055 | 763.2 | 450.7 | 400.9 | 248.3 | 268 | 231 | 211 |
| Operating Income Ratio
| 0.188 | 0.153 | 0.126 | 0.103 | 0.143 | 0.004 | 0.105 | 0.108 | 0.054 | 0.221 | 0.224 | 0.234 | 0.23 | 0.217 | 0.249 | 0.264 | 0.289 | 0.333 | 0.321 | 0.256 | 0.237 | 0.292 | 0.211 | 0.258 | 0.246 | 0.245 |
| Total Other Income Expenses Net
| -319.7 | -660.6 | -361.3 | -997.7 | -231.7 | -1,129 | -941.1 | -688 | -950.1 | -417.6 | -263.7 | -266.4 | -75.2 | -238.7 | -148.3 | -68.5 | -194.7 | -6.1 | -56.6 | -81.1 | -90.8 | -12 | -7.4 | 0 | 0 | 0 |
| Income Before Tax
| 1,067.3 | 403.5 | 499 | -274.4 | 905.8 | -271.1 | 479.6 | 401.6 | 12.3 | 943.9 | 981.1 | 990.1 | 978.9 | 860.2 | 998.2 | 1,121.8 | 1,131.6 | 1,169 | 1,040.7 | 731.5 | 437.5 | 388.9 | 240.9 | 268 | 231 | 211 |
| Income Before Tax Ratio
| 0.144 | 0.058 | 0.073 | -0.039 | 0.113 | -0.034 | 0.061 | 0.052 | 0.002 | 0.202 | 0.212 | 0.221 | 0.22 | 0.204 | 0.244 | 0.272 | 0.29 | 0.334 | 0.317 | 0.245 | 0.23 | 0.283 | 0.204 | 0.258 | 0.246 | 0.245 |
| Income Tax Expense
| 42.2 | 112.3 | 53.5 | -137 | -225.7 | 108.2 | -1,359.6 | 100 | -36.6 | 224.9 | 221.9 | 237.2 | 218.9 | 263.3 | 280.8 | 272.3 | 357.9 | 334 | 307.3 | 189.6 | 146.8 | 131.1 | 91.1 | 92 | 81 | 66 |
| Net Income
| 1,024 | 231.4 | 401.6 | -137.4 | 1,131.6 | -379.2 | 1,839.6 | 302.9 | 49.7 | 720.1 | 761 | 755 | 760.8 | 596.9 | 717.4 | 848.6 | 773.2 | 834.5 | 732.5 | 541.8 | 346.3 | 257.8 | 149.8 | 176 | 150 | 145 |
| Net Income Ratio
| 0.138 | 0.033 | 0.059 | -0.02 | 0.142 | -0.048 | 0.235 | 0.039 | 0.008 | 0.154 | 0.165 | 0.169 | 0.171 | 0.141 | 0.175 | 0.206 | 0.198 | 0.239 | 0.223 | 0.182 | 0.182 | 0.188 | 0.127 | 0.169 | 0.16 | 0.168 |
| EPS
| 4.91 | 1.39 | 1.93 | -0.66 | 5.52 | -1.86 | 9.11 | 1.51 | 0.27 | 4.26 | 4.49 | 4.32 | 4.06 | 2.98 | 3.34 | 3.73 | 3.28 | 3.43 | 2.96 | 2.22 | 1.67 | 1.33 | 0.77 | 0.91 | 0.77 | 0.75 |
| EPS Diluted
| 4.88 | 1.38 | 1.91 | -0.66 | 5.47 | -1.86 | 9.03 | 1.5 | 0.26 | 4.19 | 4.43 | 4.29 | 4.03 | 2.97 | 3.32 | 3.72 | 3.26 | 3.4 | 2.93 | 2.19 | 1.64 | 1.31 | 0.77 | 0.91 | 0.77 | 0.75 |
| EBITDA
| 2,338.7 | 1,990.5 | 1,955.3 | 1,756 | 2,271.1 | 2,175.4 | 2,792.6 | 2,415.5 | 1,935.6 | 1,385 | 1,673.4 | 1,692.5 | 1,459.2 | 1,734.3 | 1,652.8 | 1,502.1 | 1,577.5 | 1,374.8 | 1,353.9 | 1,106.7 | 735.6 | 426.2 | 271.7 | 291.1 | 253 | 237 |
| EBITDA Ratio
| 0.316 | 0.287 | 0.286 | 0.25 | 0.285 | 0.274 | 0.357 | 0.314 | 0.323 | 0.296 | 0.362 | 0.378 | 0.328 | 0.411 | 0.404 | 0.364 | 0.405 | 0.393 | 0.412 | 0.371 | 0.387 | 0.311 | 0.231 | 0.28 | 0.269 | 0.275 |